Stock SSORGS OXYGENTA PHARMACEUTICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Oxygenta Pharmaceutical Limited

Equities

SSORGS

INE102E01018

Delayed Bombay S.E.
Other stock markets
 12:45:33 2024-07-09 am EDT 		5-day change 1st Jan Change
33.7 INR -0.35% Intraday chart for Oxygenta Pharmaceutical Limited +4.56% +8.15%
May. 30 Oxygenta Pharmaceutical Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
May. 21 Oxygenta Pharmaceutical Limited announced that it has received INR 32 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Oxygenta Pharmaceutical Limited announced that it has received INR 32 million in funding
CI
Oxygenta Pharmaceutical Limited announced that it expects to receive INR 32 million in funding
CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Oxygenta Pharmaceutical Limited Appoints Miss. Dolly Mandhan as the Company Secretary of the Company Designated as the Key Managerial Personnel and Compliance Officer
CI
Oxygenta Pharmaceutical Limited Announces Board Appointments
CI
Oxygenta Pharmaceutical Limited Approves Board Changes
CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Oxygenta Pharmaceutical Limited Announces Resignation of Veerendra Babu Rangisetti as Company Secretary and Compliance Officer
CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
CI
Sunil Vishram Chawda, Manoj Sunil Chawda, Aakanksha M. Chawda and Raghavender Rao Kanuganti made an offer to acquire a 26% stake in Oxygenta Pharmaceutical Limited for approximately INR 130 million.
CI
Oxygenta Pharmaceutical Limited announced a financing transaction
CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Oxygenta Pharmaceutical Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
CI
SS Organics Adopts New Name
MT
S.S. Organics Ltd. has Changed its Name to Oxygenta Pharmaceutical Limited
CI
S.S. Organics Limited Announces Resignation of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SSORGS Stock
  4. News Oxygenta Pharmaceutical Limited